Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

被引：0
|
作者：
Lale Atahan
Ferah Yıldız
Mustafa Cengiz
Bunyamin Kaplan
Metin Özkan
Gozde Yazici
Mete Gündoğ
Ayfer Haydaroğlu
Aylin F. Korcum
Meriç Şengöz
Maktav Dinçer
Müge Akmansu
Kayıhan Engin
Mutlu Hayran
机构：
[1] Hacettepe University,Department of Radiation Oncology
[2] Erciyes University,Department of Radiation Oncology
[3] Ankara Education and Investigation Hospital of Ministry of Health,Department of Radiation Oncology
[4] Ege University,Department of Radiation Oncology
[5] Akdeniz University,Department of Radiation Oncology
[6] Marmara University,Department of Radiation Oncology
[7] İstanbul University,Department of Radiation Oncology
[8] Gazi University,Department of Radiation Oncology
[9] Uludağ University,Department of Radiation Oncology
[10] Anadolu Sağlık Merkezi,Department of Preventive Oncology
[11] Hacettepe University,undefined
来源：
Supportive Care in Cancer | 2010年 / 18卷
关键词：
Bone metastasis; Breast cancer; Radiotherapy; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 698
页数：7
相关论文
共 50 条
  • [11] The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
    Hadji, Peyman
    Ziller, May
    Maurer, Tobias
    Autenrieth, Michael
    Muth, Mathias
    Ruebel, Amelie
    May, Christoph
    Birkholz, Katrin
    Diebel, Erhardt
    Gleissner, Jochen
    Rothe, Peter
    Gschwend, Juergen E.
    JOURNAL OF BONE ONCOLOGY, 2012, 1 (03) : 88 - 94
  • [12] Acute-Phase Reactions Following Treatment with Zoledronic Acid or Denosumab: Results from a Randomized, Controlled Phase 3 Study in Patients with Breast Cancer and Bone Metastases
    Stopeck, A. T.
    Lipton, A. A.
    Campbell-Baird, C.
    von Moos, R.
    Fan, M.
    Haddock, B.
    Braun, A.
    CANCER RESEARCH, 2010, 70
  • [13] A Randomized Phase 2 Study of a Loading Dose of Ibandronate in Patients with Bone Metastases from Breast Cancer.
    Ritchie, D. M.
    Bray, C.
    Canney, P.
    CANCER RESEARCH, 2011, 71
  • [14] Zoledronic acid reduces the survival-adjusted cumulative incidence of radiotherapy to bone in patients with bone metastases from breast or prostate cancer
    Major, Pierre P.
    Cook, Richar J.
    Chen, Bee-Lian
    Zheng, Ming
    ANNALS OF ONCOLOGY, 2004, 15 : 124 - 124
  • [15] Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases
    Yamada, Kimito
    Yoshimura, Mana
    Kaise, Hiroshi
    Ogata, Akihiko
    Ueda, Naoko
    Tokuuye, Koichi
    Kohno, Norio
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (02) : 226 - 230
  • [16] HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES
    Body, J. J.
    von Moos, R.
    Stopeck, A.
    Qian, Y.
    Braun, A.
    Chung, K.
    VALUE IN HEALTH, 2010, 13 (07) : A279 - A279
  • [17] Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases
    Cleeland, C. S.
    Patrick, D. L.
    Fallowfield, L.
    Clemons, M.
    Lipton, A.
    Masuda, N.
    Qian, Y.
    Braun, A.
    Chung, K.
    CANCER RESEARCH, 2010, 70
  • [18] A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma
    Bellon, JR
    Shulman, LN
    Come, SE
    Li, XC
    Gelman, RS
    Silver, BJ
    Harris, JR
    Recht, A
    CANCER, 2004, 100 (07) : 1358 - 1364
  • [19] Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid
    Cleeland, Charles S.
    Body, Jean-Jacques
    Stopeck, Alison
    von Moos, Roger
    Fallowfield, Lesley
    Mathias, Susan D.
    Patrick, Donald L.
    Clemons, Mark
    Tonkin, Katia
    Masuda, Norikazu
    Lipton, Allan
    de Boer, Richard
    Salvagni, Stefania
    Oliveira, Celia Tosello
    Qian, Yi
    Jiang, Qi
    Dansey, Roger
    Braun, Ada
    Chung, Karen
    CANCER, 2013, 119 (04) : 832 - 838
  • [20] Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid
    Zhao, Xinmin
    Xu, Xiaofeng
    Zhang, Qunling
    Jia, Zhen
    Sun, Si
    Zhang, Jian
    Wang, Biyun
    Wang, Zhonghua
    Hu, Xichun
    BMC CANCER, 2011, 11
12345